Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Absorption of Anti-tuberculosis Drugs and Its Effect to Treatment Response in Gastrectomized Patients
Sponsor: National Cancer Center, Korea
Listed as NCT01364324, this observational or N/A phase trial focuses on Early Gastric Cancer and Tuberculosis and remains completed. Sponsored by National Cancer Center, Korea, it has been updated 11 times since 2010, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Oct 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 6 earlier versions
-
Oct 2019 — Oct 2020 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Apr 2019 — Oct 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Apr 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Center, Korea
For direct contact, visit the study record on ClinicalTrials.gov .